Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

LifeMD Q3 2026 Results: Net Loss of $4.47M, Loss Widens

LifeMD, Inc. reported a net loss of $20.6 million for the nine months ended September 30, 2026, compared to a $5.2 million loss in the prior year period. While telehealth revenue remained significant at $142 million, the company experienced an operating loss from continuing operations of $20.7 million as selling and marketing expenses increased to $76.4 million.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue44.647.7
Gross profit36.440.7
Profit before tax-4.5-4.5
Net income-4.5-3.9
EPS (diluted, $ a share)$-0.11$-0.10

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year-6.5%
Gross margin81.5%
Operating margin-10.0%
Source

10-Q filed with the SEC, NASDAQ: LFMD. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

LifeMD, Inc.: key numbers

Share price
$1.85Close, Nov 16
Market cap
$89.4M
Shares outstanding
48.33MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Offices & Clinics of Doctors of MedicineSIC 8011

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from LifeMD, Inc.

All →
4:11 PM ET 8-K
Financial Results

LifeMD Financial Results

LifeMD reported Q3 2026 revenue of $44.6 million and a GAAP net loss of $5.2 million, while improving adjusted EBITDA sequentially by $3.1 million. The company also announced it secured a $12.5 million senior secured term loan from Avenue Venture Opportunities Fund II and Avenue Growth Lending Fund to replace its previous credit facility.

Term
Q3 2026

“We ended the quarter with approximately 350,000 active subscribers, up 13% from a year ago and nearly flat from the second quarter, despite spending $9.5 million less on marketing. We’re helping more people access high-quality healthcare, and we’re getting more efficient at doing it. From May to September, cost per acquisition fell 32% while monthly media spend declined 45%. Adjusted EBITDA improved approximately $3.1 million sequentially to roughly breakeven, and we expect to sustain or improve these unit economics going forward.”

Justin Schreiber, Chairman and CEO of LifeMD

“Revenue of $44.6 million was below our guidance, and we are resetting our outlook for the fourth quarter and full year. We deliberately reduced marketing spend and prioritized longer patient commitments, and our partnerships took longer to ramp than we expected. Those factors weighed on revenue this quarter, but we believe our decisions put us in a stronger position to grow profitably.”

Justin Schreiber, Chairman and CEO of LifeMD
10:19 AM ET 8-K
Partnership

LifeMD Partnership with AT&T Services, Inc.

LifeMD entered into an exclusive strategic collaboration with AT&T to provide complimentary LifeMD memberships to over 100 million eligible AT&T wireless and fiber customers. The partnership involves a multi-phase nationwide rollout and the establishment of a joint steering committee to oversee marketing, pricing, and performance.

Counterparty
AT&T Services, Inc.
Term
1 year

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.